VIR Vir Biotechnology Inc
Market Cap
4.11B
Dayโs Range
52W Range
Volume (3M)
843.15K
Price-Earnings Ratio
3.63
Revenue
2.38B
Vir Biotechnology Inc Latest News
View All


About Vir Biotechnology Inc
Founded in 2016, Vir Biotechnology is a clinical-stage immunology company. It works to develop therapeutic products designed to treat and prevent a range of serious infectious diseases. Operating internationally, the company has headquarters in San Francisco, California. It is listed on the NASDAQ GS stock market with the VIR ticker. Add this stock to your eToro watchlist to follow VIR share price movements.
Show More444
Employees
San Francisco, California, US
HQ
2016
Founded
George A. Scangos, PhD
CEO
Upcoming Earnings
23
FEB
REPORTS
Vir Biotechnology Inc Q4 2022 earnings report is expected to be released after market open
Get insight into a company's sustainability using ESG (environmental, social, and governance) scores.
0
100
43
Low
Industry
Avg. 45
36
Environment
37
Social
53
Governance
People Also Bought
AMR Alpha Metallurgical Resources, Inc -1.52%
- DINO HF Sinclair Corp. -3.75%
- TA TravelCenters of America LLC -3.06%
NEX NexTier Oilfield Solutions Inc -3.07%
- CRK Comstock Resources Inc 0.24%
- PUMP ProPetro Holding Corp -1.55%
CNM Core & Main Inc 2.27%
TEX Terex Corporation 1.35%